[{"NetIncomeLoss_2_Q2_USD":-65757000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-26780000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2835000.0,"OtherAssetsNoncurrent_0_Q2_USD":2243000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":168443000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":28087000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":611955000.0,"Liabilities_0_Q2_USD":231814000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":292000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":353000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":37392000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":37785000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-65465000.0,"RepaymentsOfLongTermCapitalLeaseObligations_2_Q2_USD":80000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":13062000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":438000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":42333000.0,"ProceedsFromSaleOfShortTermInvestments_2_Q2_USD":17218000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":299911000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":45633000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":19912000.0,"ContractWithCustomerLiability_0_Q2_USD":6000000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":230000000.0,"PaymentsToAcquireAvailableForSaleSecurities_2_Q2_USD":38804000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2673000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":5012000.0,"CommonStockSharesIssued_0_Q2_shares":37937000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2_Q2_USD":2006000.0,"DeferredRevenueNoncurrent_0_Q2_USD":1040000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":69284000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-30000.0,"InventoryWriteDown_2_Q2_USD":14000.0,"PaymentsOfFinancingCosts_2_Q2_USD":7403000.0,"AssetsFairValueDisclosure_0_Q2_USD":241248000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":47000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-7143000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-1275000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":332000.0,"AccountsReceivableNetCurrent_0_Q2_USD":22016000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":129000.0,"IncreaseDecreaseInInventories_2_Q2_USD":6559000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":69000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":1075000.0,"CommonStockValue_0_Q2_USD":4000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":2814000.0,"ContractWithCustomerAssetNet_0_Q2_USD":0.0,"InvestmentIncomeInvestmentExpense_2_Q2_USD":6999000.0,"InvestmentIncomeInvestmentExpense_1_Q2_USD":4116000.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":1900000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-3117000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":147246000.0,"UnamortizedDebtIssuanceExpense_0_Q2_USD":62692000.0,"CostsAndExpenses_2_Q2_USD":100603000.0,"CostsAndExpenses_1_Q2_USD":46363000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":150000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":5930000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":80266000.0,"Assets_0_Q2_USD":346502000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-5129000.0,"CommonStockSharesOutstanding_0_Q2_shares":37937000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":6800000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":438000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q2_USD":167308000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-65628000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-27064000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3660000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-50139000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":6996000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":80266000.0,"CostOfRevenue_2_Q2_USD":21729000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":139440000.0,"CostOfRevenue_1_Q2_USD":10712000.0,"DeferredRevenueCurrent_0_Q2_USD":5008000.0,"AccountsPayableCurrent_0_Q2_USD":5205000.0,"NonoperatingIncomeExpense_2_Q2_USD":-14234000.0,"NonoperatingIncomeExpense_1_Q2_USD":-3305000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":168443000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":1122000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3198000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":9641000.0,"PaymentsOfDebtExtinguishmentCosts_2_Q2_USD":4845000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":20837000.0,"NetIncomeLoss_1_Q2_USD":-27133000.0,"LiabilitiesCurrent_0_Q2_USD":35379000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-497709000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":79828000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":5365000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":354000.0,"GainLossOnSaleOfInvestments_2_Q2_USD":-300000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":23511000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":0.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-5493000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":49209000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":22604000.0,"OperatingIncomeLoss_2_Q2_USD":-51394000.0,"OperatingIncomeLoss_1_Q2_USD":-23759000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":80266000.0,"InventoryNet_0_Q2_USD":25988000.0,"InvestmentIncomeInterest_2_Q2_USD":1183000.0,"InvestmentIncomeInterest_1_Q2_USD":479000.0,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":346502000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":12546000.0,"PreferredStockSharesAuthorized_0_Q2_shares":15000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8094000.0,"ProceedsFromIssuanceOfWarrants_2_Q2_USD":737000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":4319000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":449000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.76,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.72,"StockholdersEquity_0_Q2_USD":114688000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":15739000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":33241000.0,"Ticker":"NSTG","CIK":"1401708","name":"NANOSTRING TECHNOLOGIES INC","OfficialName":"NanoString Technologies Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"995164151.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]